Skip to main content

Find Clinical Trials

Home
Conditions
Carcinoma, Non-Small-Cell Lung

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,709 public trials 1,044 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Completed

A Safety and Efficacy Study of INC280 and Gefitinib in Patients With EGFR Mutated, c-MET-amplified NSCLC Who Have Progressed After EGFRi Treatment

NCT01610336

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +13 more
Locations: Novartis Investigative Site Woolloongabba, Queensland, Australia

Novartis Investigative Site East Bentleigh, Victoria, Australia

Novartis Investigative Site Auckland, Australia

Novartis Investigative Site Leuven, Belgium

View all 31 locations

View Trial Details

Completed

SBRT (Stereotactic Body Radiation Therapy) vs. Surgery in High Risk Patients With Early Stage Lung Cancer

NCT02562027

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Completed

Validation of a Screening Tool in Geriatric Oncology

NCT00963911

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +50 more
Locations: Institut Bergonie Bordeaux, France

View Trial Details

Completed

Phase 2 Study of EC145 Alone Versus EC145+Docetaxel Versus Docetaxel Alone in Participants With FR(++) 2nd Line Non Small Cell Lung Cancer

NCT01577654

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +12 more
Locations: Not specified

View Trial Details

Completed

LDK378 in Patients With ALK Positive NSCLC Previously Treated With Alectinib.

NCT02450903

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +13 more
Locations: Novartis Investigative Site Nagoya, Aichi-ken, Japan

Novartis Investigative Site Kashiwa, Chiba, Japan

Novartis Investigative Site Fukuoka, Japan

Novartis Investigative Site Sakyo Ku, Kyoto, Japan

View Trial Details

Completed

MK-3475 in Melanoma and NSCLC Patients With Brain Metastases

NCT02085070

Conditions: Brain Diseases, Brain Metastases, Brain Neoplasms, +25 more
Locations: Smilow Cancer Center at Yale New Haven Hospital New Haven, Connecticut, United States

View Trial Details

Completed

T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Cancer

NCT01967823

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +36 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Assessment of the 90-day Mortality Risk Score After VATS Lobectomy

NCT04799509

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations: Not specified

View Trial Details

Completed

Adjuvant CCRT vs CT in Minimal N2 NSCLC

NCT01066234

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Samsung Medical Center Seoul, South Korea

View Trial Details

Completed

Gilotrif (Afatinib) in Advanced Non-Small Cell Lung Cancer Patients Pre-treated With Erlotinib or Gefitinib

NCT02747953

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Not specified

View Trial Details